Ticker > Company >

Dishman Carbogen Amc share price

Dishman Carbogen Amcis Ltd.

NSE: DCAL BSE: 540701 SECTOR: Pharmaceuticals & Drugs  1.08 L   204   20

266.65
-5.00 (-1.84%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 271.85

Today's Low

₹ 264.3

52 Week High

₹ 307.8

52 Week Low

₹ 161.35

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

4180.62 Cr.

Enterprise Value

4771.77 Cr.

No. of Shares

15.68 Cr.

P/E

0

P/B

1.04

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  257.24

CASH

87.41 Cr.

DEBT

678.56 Cr.

Promoter Holding

59.32 %

EPS (TTM)

₹  -0.24

Sales Growth

22.14%

ROE

-0.24 %

ROCE

0.85%

Profit Growth

87.08 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year22.14%
3 Year9.25%
5 Year-7.19%

Profit Growth

1 Year87.08%
3 Year19.05%
5 Year-176.16%

ROE%

1 Year-0.24%
3 Year-1.18%
5 Year-1.8%

ROCE %

1 Year0.85%
3 Year-0.24%
5 Year-0.81%

Debt/Equity

0.1684

Price to Cash Flow

74.91

Interest Cover Ratio

0.5621

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 59.32 0.00
Mar 2025 59.32 0.00
Dec 2024 59.32 0.00
Sep 2024 59.32 0.00
Jun 2024 59.32 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 18.7857838503393% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 40.5972 days.
  • The company has a high promoter holding of 59.32%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.23493559093295.

 Limitations

  • The company has shown a poor revenue growth of 9.25288739013015% for the Past 3 years.
  • Company has a poor ROE of -1.17536666666667% over the past 3 years.
  • Company has a poor ROCE of -0.235666666666667% over the past 3 years
  • Company has low Interest coverage ratio of 0.5621.
  • The company has a low EBITDA margin of 1.32547290734824% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 40.0552.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 103.41 93.29 97.04 106.1 62.86
Total Expenditure 88.51 79.89 74.08 85.57 59.43
Operating Profit 14.9 13.4 22.96 20.53 3.43
Other Income 11.59 23.93 -8.01 5.47 37.42
Interest 15.73 15.59 17.77 21.31 20.26
Depreciation 16.32 16.3 16.48 16.1 16.47
Exceptional Items 0 0 0 0 0
Profit Before Tax -5.56 5.44 -19.3 -11.41 4.12
Tax -2.09 -8.81 -6.02 -4.04 1.45
Profit After Tax -3.47 14.25 -13.28 -7.37 2.67
Adjusted EPS (Rs) -0.22 0.91 -0.85 -0.47 0.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 200.32 306.61 402.55 327.35 399.84
Total Expenditure 253.11 272.82 394.79 320.55 328.05
Operating Profit -52.79 33.79 7.76 6.8 71.79
Other Income 66.29 66.11 52.16 63.05 32.98
Interest 34.17 37.23 57.92 68.19 70.4
Depreciation 141.35 140.07 96.2 101.61 65.2
Exceptional Items 0 -5.91 -2 -3.05 0
Profit Before Tax -162.02 -83.31 -96.2 -103 -30.83
Tax 64.12 -52.84 -37.33 -26.59 -20.96
Net Profit -232.81 -31.55 -58.87 -76.41 -9.87
Adjusted EPS (Rs.) -14.42 -1.94 -3.75 -4.87 -0.63

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 31.36 31.36 31.36 31.36 31.36
Total Reserves 4643.26 4200.42 4082.95 4021.22 3999.12
Borrowings 144.41 134.42 162.57 157.37 247.69
Other N/C liabilities 348.96 444.04 409.68 395.1 339.2
Current liabilities 530.88 551.19 641.6 618.73 652.1
Total Liabilities 5698.87 5361.43 5328.16 5223.78 5269.47
Assets
Net Block 1509.65 1355.98 1382.3 1415.63 1401.2
Capital WIP 79.36 114.12 141.88 73.35 40.7
Intangible WIP 41.84 3.65 1.01 0.7 0
Investments 2814.87 2811.09 2837.36 2834.26 2824.85
Loans & Advances 529.74 310.14 315.19 311.95 325.95
Other N/C Assets 0.35 0.66 0.81 0.67 1.79
Current Assets 723.06 765.79 649.61 587.22 674.98
Total Assets 5698.87 5361.43 5328.16 5223.78 5269.47
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -168.69 -84.39 -96.2 -103 -30.83
Adjustment 128.11 117.32 100.96 116.86 95.67
Changes in Assets & Liabilities 46.25 200.55 -54.11 11.53 -6.76
Tax Paid -7.18 -6.13 -3.55 -1.22 -2.27
Operating Cash Flow -1.51 227.35 -52.9 24.17 55.81
Investing Cash Flow 62.07 -172.67 40.71 96.57 -79.64
Financing Cash Flow -70.53 -46.16 1.38 -130.76 87.51
Net Cash Flow -9.97 8.52 -10.81 -10.02 63.68

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 59.32 59.32 59.32 59.32 59.32
adimans technologies llp ... - - - - 59.32
adimans technologies llp 59.32 59.32 59.32 59.32 -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 40.68 40.68 40.68 40.68 40.68
hbm healthcare investment... 3.55 3.55 3.55 3.57 3.57
investor education and pr... - 0.02 0.02 0.02 0.02
llp 0.39 0.30 0.81 0.79 0.73
massachusetts institute o... 1.95 1.95 1.95 2.27 2.28
mukul mahavir agrawal 5.74 5.50 5.50 5.50 5.50
investor education and pr... 0.02 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit FITCH
Credit FITCH
Credit INDIA RATINGS & RESEARCH
Credit FITCH
Credit FITCH
TYPE AGENCY Link
TYPE AGENCY Link
Research HDFC Securities
Research BOB Capital Market
Research Nirmal Bang Institutional
Research HDFC Securities

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY22
Concall Q3FY24
Concall Q3FY24
Concall Q3FY23
Concall Q1FY25
Concall Q1FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY26
Presentation Q1FY22
Presentation Q1FY21

Company News

Dishman Carbogen Amc Stock Price Analysis and Quick Research Report. Is Dishman Carbogen Amc an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Dishman Carbogen Amc. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Dishman Carbogen Amc has a PE ratio of -1124.84237074401 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Dishman Carbogen Amc has ROA of -0.1881% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Dishman Carbogen Amc has a Current ratio of 1.0351.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Dishman Carbogen Amc has a ROE of -0.2442%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Dishman Carbogen Amc has a Debt to Equity ratio of 0.1684 which means that the company has low proportion of debt in its capital.

  • Sales growth: Dishman Carbogen Amc has reported revenue growth of 22.1445% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Dishman Carbogen Amc for the current financial year is 17.9546818727491%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Dishman Carbogen Amc is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Dishman Carbogen Amc is Rs -0.2379. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Dishman Carbogen Amc in Ticker for free. Also, one can get the intrinsic value of Dishman Carbogen Amc by using Valuation Calculators, which are available with a Finology ONE subscription. 

Dishman Carbogen Amc FAQs

Q1. What is Dishman Carbogen Amc share price today?
Ans: The current share price of Dishman Carbogen Amc is Rs 267.6.

Q2. What is the market capitalisation of Dishman Carbogen Amc?
Ans: Dishman Carbogen Amc has a market capitalisation of Rs 4195.5156222 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Dishman Carbogen Amc?
Ans: The PE ratio of Dishman Carbogen Amc is -1124.84237074401 and the P/B ratio of Dishman Carbogen Amc is 1.04025871187516, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Dishman Carbogen Amc share?
Ans: The 52-week high share price of Dishman Carbogen Amc is Rs 307.98, and the 52-week low share price of Dishman Carbogen Amc is Rs 161.21.

Q5. Does Dishman Carbogen Amc pay dividends?
Ans: Currently, Dishman Carbogen Amc does not pay dividends. Dividend yield of Dishman Carbogen Amc is around 0%.

Q6. What are the face value and book value of Dishman Carbogen Amc shares?
Ans: The face value of Dishman Carbogen Amc shares is Rs 2, while the book value per share of Dishman Carbogen Amc is around Rs 257.2437. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Dishman Carbogen Amc?
Ans: Dishman Carbogen Amc has a total debt of Rs 678.56 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Dishman Carbogen Amc?
Ans: The ROE of Dishman Carbogen Amc is -0.2442% and ROCE of Dishman Carbogen Amc is 0.8523%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Dishman Carbogen Amc a good buy for the long term?
Ans: The Dishman Carbogen Amc long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Dishman Carbogen Amc undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Dishman Carbogen Amc appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Dishman Carbogen Amc’s financials?
Ans: You can review Dishman Carbogen Amc’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Dishman Carbogen Amc
X